Evolet Pharmaceuticals Private Limited

Evolet Pharmaceuticals Private Limited - pharma in Bhorakalan, Haryana, India. FY 2026 financials & compliance.
CIN U24230HR2005PTC127251 Incorporated 06 April 2005 ROC Delhi HQ Bhorakalan, Haryana, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2025
₹35.41 Cr
▼ 34% YoY
Net loss · FY 2025
₹1.82 Cr
Net margin -5.1%
EBITDA · FY 2025
-₹22.27 Lakh
EBITDA margin -0.6%
Authorised capital
₹28 Cr
Registered with MCA
Paid-up capital
₹27.74 Cr
Issued & subscribed
Open charges
₹2 Cr
Satisfied ₹8.4 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
82
Provident fund records

About Evolet Pharmaceuticals Private Limited

Data last updated:

Evolet Pharmaceuticals Private Limited is a private limited company based in Bhorakalan, Haryana, India, a subsidiary of Evolet Healthcare Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 April 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230HR2005PTC127251. Its GSTIN is 06AAFCA1568F1ZW (Haryana). The company holds 6 GST registrations, of which 3 are active.

The company has an authorised share capital of ₹28 Cr and a paid-up capital of ₹27.74 Cr. It was formerly known as Anchal Lifescience Private Limited. It is led by directors including Safarali Safarov and Jamshed Mirzoev.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Bhorakalan, Haryana.

As per the financials filed for FY 2025, the company reported a revenue of ₹35.41 Cr, a decline of 34% compared to the previous year. For the same year it recorded a net loss of ₹1.82 Cr (net margin -5.1%) and EBITDA of -₹22.27 Lakh (EBITDA margin -0.6%).

The company has about 82 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹8.4 Cr on record. Court records list 48 cases involving the company, including 35 filed by the company and 13 filed against it; 11 cases are pending.

Evolet Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0004940). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website anchallifescience.com.

Company details

CIN U24230HR2005PTC127251
Registration Number 127251
Incorporation Date 06 April 2005
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Evolet Healthcare Private Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-UK-06-0004940

Name history

Evolet Pharmaceuticals has undergone 2 name changes throughout its history. The company was previously known as Evolet Pharmaceuticals Private Limited, and Anchal Lifescience Private Limited. The current legal name is Evolet Pharmaceuticals Private Limited.

Company NameStatus
Evolet Pharmaceuticals Private LimitedCurrent
Anchal Lifescience Private LimitedPrevious

CIN history

Evolet Pharmaceuticals has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24230HR2005PTC127251, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230HR2005PTC127251Current
U24230GJ2005PTC045834Previous
U24230DL2005PTC322716Previous

Recognitions & Rankings of Evolet Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-UK-06-0004940

Contact details

Evolet Pharmaceuticals Private Limited's registered office is in Bhorakalan, Haryana. Its website is anchallifescience.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Unit No.1101 11th Floor Imperia Mindspace, Golf Course Ext. Road Sec.62 Maidawas, Bhorakalan, Haryana, India – 122413
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Evolet Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Evolet Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Evolet Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Evolet Pharmaceuticals Private Limited, buy the company report.

Financials of Evolet Pharmaceuticals Private Limited

FY 2024 filings available

Evolet Pharmaceuticals Private Limited reported revenue of ₹35.41 Cr (down 34% YoY) for FY 2025.

Revenue · FY 2025
₹35.41 Cr ▼ 34%
Net loss · FY 2025
₹1.82 Cr margin -5.1%
EBITDA · FY 2025
-₹22.27 Lakh margin -0.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 34%
EBITDA CAGR growth
1 year
▼ 113%

Revenue fell 34% in the latest year. EBITDA fell 113% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹22.27 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.82 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-0.6%
Net Profit Margin-5.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Evolet Pharmaceuticals Private Limited, buy the company report.

Board of directors of Evolet Pharmaceuticals Private Limited

Evolet Pharmaceuticals has 4 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Safarali SafarovDirector18 Feb 20224 Years 8 MonthsCurrent
Jamshed MirzoevDirector08 May 20197 Years 5 MonthsCurrent
Akobir ZohidovDirector04 Nov 20169 Years 11 MonthsCurrent
Ilkhomzhon MirzoevDirector27 Jul 20215 Years 3 MonthsCurrent

Auditor

Evolet Pharmaceuticals Private Limited is audited by RKCA & Co. LLP (erstwhile known as RKACA & Associates, LLP) for the financial year 2024.

Auditor firmFinancial yearFirm registration number
RKCA & Co. LLP (erstwhile known as RKACA & Associates, LLP)FY 2024014372N/N500004

Shareholding

The shareholding of Evolet Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Evolet Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹2 Cr
Satisfied charges
₹8.4 Cr
Breakdown by lending institutions
Others₹2.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
22 Jan 2018100153992Others₹2 CrOpen
01 Mar 201310419646Axis Bank Ltd.₹10 LakhSatisfied
07 Dec 201210398446Axis Bank Limited₹1.9 CrSatisfied
24 Nov 201210398445Axis Bank Limited₹1.5 CrSatisfied
19 Jun 200610008798State Bank of India₹2.45 CrSatisfied

To see the full charge records of Evolet Pharmaceuticals Private Limited, buy the company report.

Total charge records: 6 View all charges

MSME payment delays

Evolet Pharmaceuticals Private Limited has 7 MSME Form 1 returns on record between 2019 and 2023, listing 1,692 overdue payments to 129 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 129)

SupplierAmount dueDue sinceReported on
an individual supplier
Bajaj Healthcare Limited
Hufort Healthcare Private Limited
Shreeji Bottle Trading Company(Gujrat)
Gabs Lab Private Limited

To see the full MSME payment records of Evolet Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Evolet Pharmaceuticals Private Limited has a workforce of 82 employees on its EPFO records as of Mar 06, 2025, across 1 active EPFO establishment.

Employee count
82
Active EPFO establishments
1
Employee growth
-6.82%

GST

Evolet Pharmaceuticals has 6 GST registrations: 3 active and 3 cancelled or inactive.

Total GSTINs
6
Active
3
Cancelled / inactive
3
GSTINStateStatusRegistered on
06AAFCA1568F1ZWHaryanaActive14 May 2021
05AAFCA1568F1ZYUttarakhandActive01 Jul 2017
05AAFCA1568F2ZXUttarakhandActive12 Oct 2021

To see the full GST registrations and return filing status of Evolet Pharmaceuticals Private Limited, buy the company report.

Recent activity

Evolet Pharmaceuticals Private Limited has 15 board changes on record since 2012: 5 appointments and 10 cessations. The latest: Safarali Safarov ceased to be Additional Director on 30 Sep 2022.

AGM
Evolet Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Evolet Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Safarali Safarov ceased to be Additional Director.
Appointed
Safarali Safarov was appointed as Director.
Ceased
Ilkhomzhon Mirzoev ceased to be Additional Director.
Ceased
Khayrullo Avgonov ceased to be Additional Director.
Ceased
Shahnazar ceased to be Director.
Appointed
Ilkhomzhon Mirzoev was appointed as Director.
Appointed
Vijay Pratap Singh Gautam was appointed as Company Secretary.
Ceased
Jamshed Mirzoev ceased to be Additional Director.
Appointed
Jamshed Mirzoev was appointed as Director.
Charges
A charge with Others of Rs. 2.00 Cr registered on 22 Jan 2018 with Charge ID 100153992 was modified on 13 Feb 2018.

19 earlier events are in the company report.

Frequently asked questions

Evolet Pharmaceuticals is an active private limited company based in Bhorakalan, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 April 2005 (21+ years old) and is registered under CIN U24230HR2005PTC127251.

Evolet Pharmaceuticals has 4 current directors:

The latest financial statements of Evolet Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Evolet Pharmaceuticals is 06AAFCA1568F1ZW, registered in Haryana. The company has 6 GST registrations in all, of which 3 are active and 3 are cancelled or inactive. Other active GSTINs include 05AAFCA1568F1ZY (Uttarakhand), 05AAFCA1568F2ZX (Uttarakhand).

The CIN (Corporate Identification Number) of Evolet Pharmaceuticals is U24230HR2005PTC127251. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Evolet Pharmaceuticals has 48 court cases on record: 35 filed by the company and 13 filed against it. 11 are pending. Most are in the district courts.

Evolet Pharmaceuticals was incorporated on 06 April 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.

Safarali Safarov ceased to be Additional Director on 30 Sep 2022. Safarali Safarov was appointed as Director on 18 Feb 2022. Ilkhomzhon Mirzoev ceased to be Additional Director on 30 Nov 2021. Evolet Pharmaceuticals has 15 board changes on record in total.

Yes, Evolet Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-UK-06-0004940).

Evolet Pharmaceuticals has 7 MSME Form 1 returns on record between 2019 and 2023, listing 1,692 overdue payments to 129 micro and small suppliers. The latest return was filed on 27 Aug 2023.

Evolet Pharmaceuticals can be reached through the website anchallifescience.com. Its registered office is in Bhorakalan, Haryana, India.